A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : EP / efflux pump

[Related PubMed/MEDLINE]
Total Number of Papers: 15
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   EP  (>> Co-occurring Abbreviation)
Long Form:   efflux pump
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Promising Antituberculosis Activity of Piperine Combined with Antimicrobials: A Systematic Review. TB
2019 Selenocompounds as Novel Antibacterial Agents and Bacterial Efflux Pump Inhibitors. MRSA
2015 Docking analysis insights quercetin can be a non-antibiotic adjuvant by inhibiting Mmr drug efflux pump in Mycobacterium sp. and its homologue EmrE in Escherichia coli. ---
2015 Impact of efflux in the development of multidrug resistance phenotypes in Staphylococcus aureus. ---
2014 Efflux pumps of Gram-negative bacteria: what they do, how they do it, with what and how to deal with them. ---
2013 7-Hydroxy-(E)-3-phenylmethylene-chroman-4-one analogues as efflux pump inhibitors against Mycobacterium smegmatis mc 155. ---
2013 Chlorhexidine resistance in a Gram-negative bacterium isolated from an aquatic source. MFS, RND
2013 Influence of induced ciprofloxacin resistance on efflux pump activity of Klebsiella pneumoniae. CCCP, EtBr, MICs
2012 Efflux pumps of Mycobacterium tuberculosis play a significant role in antituberculosis activity of potential drug candidates. ABC, KO, MFS, PAbetaN, SMR, WT
10  2011 The plant alkaloid piperine as a potential inhibitor of ethidium bromide efflux in Mycobacterium smegmatis. EtBr
11  2010 Evaluation of efflux activity of bacteria by a semi-automated fluorometric system. EB, EPIs, MDR, PBS
12  2010 Farnesol, a potential efflux pump inhibitor in Mycobacterium smegmatis. CCCP, EPIs, EtBr, M. smegmatis, MIC
13  2010 Identification of efflux-mediated multi-drug resistance in bacterial clinical isolates by two simple methods. EB, EPI, MDR
14  2008 Identification of mutations related to streptomycin resistance in clinical isolates of Mycobacterium tuberculosis and possible involvement of efflux mechanism. STR
15  2007 In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae. ---